Results 21 to 30 of about 41,988 (210)

Tobacco dependence and schizophrenia: Tunisian cross-sectional study of 50 cases

European Psychiatry, 2022
Introduction Tobacco-use is currently one of the major public health problems and is more common among patients with schizophrenia. Objectives We aimed in this study to estimate the prevalence of smoking in a population of patients with schizophrenia ...
M. Jabeur, L. Gassab, I. Anes, A. Ben Haouala, F. Zaafrane, L. Gaha   +5 more
doaj   +1 more source

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting

Journal of Market Access & Health Policy, 2017
Background: Adverse event (AE) reporting in clinical trials does not fully capture the patient-level perspective and comparing tolerability across treatments or among studies is difficult.
Clément François, Alice Guiraud-Diawara, Christophe Lançon, Pierre Michel Llorca, Ann Hartry, Lene Hammer-Helmich, Djamel A. Zighed, Adrian Tanasescu, Mondher Toumi   +8 more
doaj   +1 more source

Treatment of early onset schizophrenia: Recent trends, challenges and future considerations

Frontiers in Psychiatry, 2012
Early onset schizophrenia (onset before adulthood) is a rare, severe and chronic form of schizophrenia. Antipsychotic treatment remains the mainstay of treatment although current medications provide suboptimal response at best.
Nora S Vyas, Nitin eGogtay
doaj   +1 more source

Quetiapine-induced bicytopenia. Case report and literature review

European Psychiatry, 2021
Introduction Low white blood cell counts and agranulocytosis are a relatively rare side effect of atypical antipsychotic treatment. Like most atypical antipsychotics, quetiapine only has a 1%-4% risk of low blood cell count.
T. Gutiérrez Higueras, S. Vicent Forés, S. Sainz De La Cuesta Alonso, F. Calera Cortés   +3 more
doaj   +1 more source

A randomized-controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia

Frontiers in Pharmacology, 2013
Objective: Medication adherence is extremely important in preventing relapse and lowering symptoms in schizophrenic patients. However, estimates show that nearly half of these patients have poor adherence. The Brief Adherence Rating Scale (BARS) seems to
Emmanuel eStip, Emmanuel eStip, Emmanuel eStip, Philippe D. Vincent, Philippe D. Vincent, Philippe D. Vincent, Catherine eGuevremont, Simon eZhornitsky, Constantin eTranulis, Constantin eTranulis, Constantin eTranulis, Juliette eSablier, Juliette eSablier   +12 more
doaj   +1 more source

Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia

Neuropsychopharmacology Reports, 2020
Aim It is well accepted that early improvement with antipsychotics predicts subsequent response in patients with schizophrenia. However, no study has examined the contribution of individual symptoms rather than overall symptom severity as the predictors.
Kamiyu Ogyu, Yoshihiro Noda, Kazunari Yoshida, Shin Kurose, Fumi Masuda, Yu Mimura, Hana Nishida, Eric Plitman, Ryosuke Tarumi, Sakiko Tsugawa, Masataka Wada, Takahiro Miyazaki, Hiroyuki Uchida, Ariel Graff‐Guerrero, Masaru Mimura, Shinichiro Nakajima   +15 more
doaj   +1 more source

CLOZAPINE AND HALOPERIDOL INCREASE THE EXPRESSION OF PED/PEA-15: A PUTATIVE NOVEL MECHANISM FOR ANTIPSYCHOTIC-RELATED DIABETES [PDF]

, 2008
Schizophrenia is a serious disorder that affects 1% of the population in the United States and Europe, and is associated with a significant reduction in life expectancy that approaches 20% compared with that of the general population.
Panariello, Fabio
core   +1 more source

Successful high dose antipsychotic treatment with cariprazine in patients on the schizophrenia spectrum: Real-world evidence from a Spanish hospital setting

Frontiers in Psychiatry, 2023
Real-world evidence fills in an important gap by providing data on the effectiveness and tolerability of new medications in everyday patients. In this data collection form a Spanish hospital, the effectiveness and tolerability of cariprazine were ...
Lluis Niell Galmes, Elmars Rancans
doaj   +1 more source

Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder

Brain Sciences
Background/Objectives: Precision medicine is not just hype. Instead, it represents a high bar for developing more effective, safer, and better-tolerated therapies in medicine, without exception in psychiatry, including bipolar disorder (BD). A burgeoning
Michele Fornaro, Alessandro Miola, Domenico De Berardis, Alessio Squassina, Mirko Manchia, Marco Solmi   +5 more
doaj   +1 more source

Pulmonary embolism in a patient with neuroleptic malignant syndrome

Hematology Reports, 2018
Venous thromboembolism is one of the complications in patients prescribed antipsychotic medications. Neuroleptic malignant syndrome (NMS) is a rare side effect of antipsychotic medications in this population.
Mosaad Almegren
doaj   +1 more source